Understanding and preventing liver cancer related to metabolic dysfunction
Admin Core
['FUNDING_P01'] · BAYLOR COLLEGE OF MEDICINE · NIH-10874539
This study is looking for ways to lower the risk of liver cancer by exploring how metabolic issues and fatty liver disease might play a role, and it's designed for people who want to understand more about their liver health.
Quick facts
| Phase | ['FUNDING_P01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | BAYLOR COLLEGE OF MEDICINE (nih funded) |
| Locations | 1 site (HOUSTON, UNITED STATES) |
| Trial ID | NIH-10874539 on ClinicalTrials.gov |
What this research studies
This research focuses on reducing liver cancer mortality by investigating risk factors associated with metabolic dysfunction and fatty liver disease. It aims to identify biochemical and genetic markers that contribute to the development of hepatocellular carcinoma (HCC). The project will utilize shared resources for biospecimen collection and data analysis, ensuring a comprehensive approach to understanding and preventing this disease. The leadership team at Baylor College of Medicine brings extensive experience in managing similar research initiatives.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with metabolic dysfunction or fatty liver disease who are at risk for developing hepatocellular carcinoma.
Not a fit: Patients without metabolic dysfunction or those not at risk for liver cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved prevention strategies and reduced mortality rates for patients at risk of liver cancer.
How similar studies have performed: Previous research has shown promise in identifying risk factors and preventive strategies for liver cancer, indicating that this approach has potential for success.
Where this research is happening
HOUSTON, UNITED STATES
- BAYLOR COLLEGE OF MEDICINE — HOUSTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: EL-SERAG, HASHEM B — BAYLOR COLLEGE OF MEDICINE
- Study coordinator: EL-SERAG, HASHEM B
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancer Biology, Cancer Center, Diabetes Mellitus